The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Pretransplantation Assessment of the Risk of Lymphoproliferative Disorder
Abstract
Posttransplantation lymphoproliferative disorder (PTLD) is an uncommon but often fatal complication of solid organ transplantation that occurs in approximately 3% of patients. To determine the relative importance and relationship of potential risk factors for PTLD before transplantation (i.e., Epstein-Barr virus [EBV] serostatus of the recipient and the cytomegalovirus [CMV] sero-status of the recipient and the potential donor) and the principal risk factor after transplantation (immunosuppression with antilymphocyte antibody), we analyzed the findings for the first 381 consecutive adult nonrenal transplant recipients seen at Mayo Clinic. In the absence of the other risk factors, the incidence rate of PTLD for EBV-seronegative recipients was 24 times higher (95% confidence interval [CI]: 6.2, 89) than that for EBV-seropositive recipients. The additional risk factors of therapy with OKT3 for rejection and CMV seromismatch (i.e., a negative recipient and a positive donor) each further amplified this risk four- to sixfold. Together, all three risk factors acted synergistically to increase the incidence rate of fatal and/or CNS PTLD by a factor of 654 (CI: 368, 1,162) compared with the low incidence rate (.458 cases per 100 person years) when none of these risk factors were present. Pretransplantation determination of recipient EBV and CMV serostatus can identify a subgroup of patients whose risk for severe PTLD may preclude transplantation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Starzl, T. E., Porter, K. A., Iwatsuki, S., Rosenthal, J. T., Shaw, B. W., Atchison, R. W., Nalesnik, M., Ho, M., Griffith, B. P., Hakala, T. R., et al. (1984) · The Lancet · doi:10.1016/s0140-6736(84)90994-2 · Cited by 1,234
Nalesnik, M. A., Jaffe, R., Starzl, T. E., et al. (1988) · PubMed · Cited by 700
Incidence of non-hodgkin lymphoma in kidney and heart transplant recipients
Opelz, G., & Henderson, R. (1993) · The Lancet · doi:10.1016/s0140-6736(05)80084-4 · Cited by 648
Cancers Complicating Organ Transplantation
Penn, I. (1990) · New England Journal of Medicine · doi:10.1056/nejm199012203232510 · Cited by 512
Cytomegalovirus: Biology and Infection.
(1983) · Annals of Internal Medicine · doi:10.7326/0003-4819-98-4-573_2 · Cited by 430
A Controlled Trial of Ganciclovir to Prevent Cytomegalovirus Disease after Heart Transplantation
Merigan, T. C., Renlund, D. G., Keay, S., Bristow, M. R., Starnes, V., O'Connell, J. B., Resta, S., Dunn, D., Gamberg, P., Ratkovec, R. M., et al. (1992) · New England Journal of Medicine · doi:10.1056/nejm199204303261803 · Cited by 376 · cited 2×
“Unlike reactivated CMV disease, it is little affected by antiviral prophylaxis [31].”
BackgroundRand, K. H., Pollard, R. B., & Merigan, T. C. (1978) · New England Journal of Medicine · doi:10.1056/nejm197804272981705 · Cited by 233
Calculating Confidence Intervals for Rates and Ratios
Schoenberg, B. S. (1983) · Neuroepidemiology · doi:10.1159/000110529 · Cited by 218
Payá, C. V., Wiesner, R. H., Hermans, P. E., Larson-Keller, J. J., Ilstrup, D. M., Krom, R. A. F., Rettke, S. R., & Smith, T. F. A. (1993) · Journal of Hepatology · doi:10.1016/s0168-8278(05)80245-4 · Cited by 144
Self-citationDetection of Epstein-Barr virus by polymerase chain reaction
Telenti, A., Marshall, W. F., & Smith, T. F. A. (1990) · Journal of Clinical Microbiology · doi:10.1128/jcm.28.10.2187-2190.1990 · Cited by 127
Self-citationEpstein-Barr virus and persistent graft dysfunction after liver transplantation
Telenti, A., Smith, T. F. A., Ludwig, J., Keating, M. R., Krom, R. A. F., & Wiesner, R. H. (1991) · Hepatology · doi:10.1002/hep.1840140213 · Cited by 39
Self-citation
Cited by
Kotton, C. N., Kumar, D., Caliendo, A. M., Åsberg, A., Chou, S., Danziger-Isakov, L., & Humar, A. (2013) · Transplantation · doi:10.1097/tp.0b013e31829df29d · Cited by 758
Razonable, R. R., & Humar, A. (2019) · Clinical Transplantation · doi:10.1111/ctr.13512 · Cited by 753
Infections in solid-organ transplant recipients
Patel, R., & Paya, C. V. (1997) · Clinical Microbiology Reviews · doi:10.1128/cmr.10.1.86 · Cited by 679
Self-citationCytomegalovirus in Solid Organ Transplantation
Razonable, R. R., & Humar, A. (2013) · American Journal of Transplantation · doi:10.1111/ajt.12103 · Cited by 544
EPSTEIN-BARR VIRUS-INDUCED POSTTRANSPLANT LYMPHOPROLIFERATIVE DISORDERS
Paya, C. V., Fung, J. J., Nalesnik, M. A., Kieff, E., Green, M., Gores, G., Habermann, T. M., Wiesner, R. H., Swinnen, L. J., Woodle, E. S., et al. (1999) · Transplantation · doi:10.1097/00007890-199911270-00015 · Cited by 533
Self-citation
Metadata
- Authors
- Walker, R. C., Marshall, W. F., Strickler, J. G., Wiesner, R. H., Velosa, J. A., Habermann, T. M., McGregor, C. G. A., & Paya, C. V.
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 1995-05-01
- Volume
- 20
- Issue
- 5
- Pages
- 1346-1353
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2031832264
- Cited by
- 392
- References
- 11
- FWCI
- 2.50
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.